Related Experiment Video
Updated: May 7, 2026
08:08
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
[PCR-based diagnosis of mucormycosis in tissue samples]
1LADR GmbH MVZ Dr. Kramer & Kollegen, Geesthacht, Lauenburger Str. 67, 21502, Geesthacht, Deutschland, r.bialek@ladr.de.
Der Pathologe
|October 5, 2013
Summary
Early diagnosis of invasive mucormycosis is crucial for survival. Polymerase chain reaction (PCR) assays offer rapid and specific fungal identification, improving therapeutic decisions and patient outcomes.
Area of Science:
- Mycology
- Medical Mycology
- Infectious Diseases
Context:
- Mucormycosis is a rapidly progressing, often fatal fungal infection.
- Early diagnosis is critical for effective treatment and improved survival rates.
- Current treatment options are limited, primarily relying on amphotericin B.
Purpose:
- To highlight the importance of rapid and specific fungal identification in diagnosing invasive mucormycosis.
- To evaluate the utility of Polymerase Chain Reaction (PCR) assays in complementing conventional methods.
- To emphasize how accurate fungal identification guides timely therapeutic interventions.
Summary:
- Conventional histopathology for mucormycosis has limitations in accuracy and speed.
- Polymerase chain reaction (PCR) assays targeting fungal ribosomal genes provide sensitive and rapid identification of Mucorales.
- PCR can detect fungal infections, including mixed infections, aiding in prompt diagnosis and treatment selection.
Impact:
- Rapid PCR-based identification facilitates timely initiation of appropriate antifungal therapy, such as amphotericin B.
- Accurate fungal identification improves treatment strategies and potentially increases patient survival rates.
- Retrospective PCR analyses aid in evaluating treatment efficacy and optimizing future therapeutic approaches for mucormycosis.
